Tuesday, 7 June 2011

AVI BioPharma Live Podcast 6/20/11

AVI BioPharma Live Podcast 6/20/11: "Chris Garabedian, CEO of AVI BioPharma, will participate in a live podcast hosted by PPMD on June 20, 2011 at 1:00 pm ET. Chris will review AVI’s development of eteplirsen, the company’s Phase 2 exon 51 skipping therapeutic candidate to restore dystrophin expression and treat DMD. Chris will also respond to questions submitted by email on or before June 16, 2011. Questions can be submitted by emailing info@parentprojectmd.org with the subject line: AVI Webinar. "

No comments:

Post a Comment